Andrew Leslie, Catherine Harrison, Allan Jackson, Susan Broster, Eileen Clarke, Sarah L Davidson, Colin Devon, Beverley Forshaw, Alex Philpott, Robert Tinnion, Jo Whiston, Alan C Fenton, Don Sharkey
{"title":"Tracking national neonatal transport activity and metrics using the UK Neonatal Transport Group dataset 2012-2021: a narrative review.","authors":"Andrew Leslie, Catherine Harrison, Allan Jackson, Susan Broster, Eileen Clarke, Sarah L Davidson, Colin Devon, Beverley Forshaw, Alex Philpott, Robert Tinnion, Jo Whiston, Alan C Fenton, Don Sharkey","doi":"10.1136/archdischild-2023-325532","DOIUrl":"10.1136/archdischild-2023-325532","url":null,"abstract":"<p><p>There are no internationally agreed descriptors for categories of neonatal transports which facilitate comparisons between settings. To continually review and enhance neonatal transport care we need robust categories to develop benchmarks. This review aimed to report on the development and application of key measures across a national neonatal transport service. The UK Neonatal Transport Group (UK-NTG) developed a core dataset and benchmarks for transported infants and collected annual national data. Data were reported back to teams to allow benchmarking and improvements. From 2012 to 2021, the rate of UK neonatal transfers increased from 18 to 22/1000 live births despite a falling birth rate. Neonatal transfers on nitric oxide increased until 2016 before plateauing. The proportion of transport services able to provide high frequency oscillation and servo-controlled therapeutic hypothermia increased over the study period. High-flow nasal cannula oxygen use increased, becoming the most frequently used non-invasive respiratory support mode. For infants <27 weeks of gestational age, transfers for uplift of care in the first 3 days of life have fallen from 420 (2016) to 288 (2020/2021) and for lack of neonatal capacity from 24 (2016) to 2 (2020/2021). The rate of ventilated infants completing transfer with CO<sub>2</sub> out of the benchmark range varied from 9% to 13% with marked variation between transport services' rates of hypocapnia (0-10%) and hypercapnia with acidosis (0-9%). The development of the UK-NTG dataset supports national tracking of activity and clinical trends allowing comparison of patient-focused benchmarks across teams.</p>","PeriodicalId":8177,"journal":{"name":"Archives of Disease in Childhood - Fetal and Neonatal Edition","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139563196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Siamak Yazdi, Waldemar A Carlo, Arie Nakhmani, Ernestina O Boateng, Immaculada Aban, Namasivayam Ambalavanan, Colm P Travers
{"title":"Extended CPAP or low-flow nasal cannula for intermittent hypoxaemia in preterm infants: a 24-hour randomised clinical trial.","authors":"Siamak Yazdi, Waldemar A Carlo, Arie Nakhmani, Ernestina O Boateng, Immaculada Aban, Namasivayam Ambalavanan, Colm P Travers","doi":"10.1136/archdischild-2023-326605","DOIUrl":"10.1136/archdischild-2023-326605","url":null,"abstract":"<p><strong>Objective: </strong>Optimal timing of continuous positive airway pressure (CPAP) cessation in preterm infants remains undetermined. We hypothesised that CPAP extension compared with weaning to low-flow nasal cannula (NC) reduces intermittent hypoxaemia (IH) and respiratory instability in preterm infants meeting criteria to discontinue CPAP.</p><p><strong>Design: </strong>Single-centre randomised clinical trial.</p><p><strong>Setting: </strong>Level 4 neonatal intensive care unit.</p><p><strong>Patients: </strong>36 infants <34 weeks' gestation receiving CPAP≤5 cmH<sub>2</sub>O and fraction of inspired oxygen (FiO<sub>2</sub>) ≤0.30 and meeting respiratory stability criteria.</p><p><strong>Interventions: </strong>Extended CPAP was compared with weaning to low-flow NC (0.5 L/kg/min with a limit of 1.0 L/min) for 24 hours.</p><p><strong>Outcomes: </strong>The primary outcome was IH (number of episodes with SpO<sub>2</sub><85% lasting ≥10 s). Secondary outcomes included: coefficient of variability of SpO<sub>2</sub>, proportion of time in various SpO<sub>2</sub> ranges, episodes (≥10 s) with SpO<sub>2</sub><80%, median cerebral and renal oxygenation, median effective FiO<sub>2</sub>, median transcutaneous carbon dioxide and bradycardia (<100/min for≥10 s).</p><p><strong>Results: </strong>The median (IQR) episodes of IH per 24-hour period was 20 (6-48) in the CPAP group and 76 (18-101) in the NC group (p=0.03). Infants continued on CPAP had less bradycardia, time with SpO<sub>2</sub> <91% and <85%, and lower FiO<sub>2</sub> (all p<0.05). There were no statistically significant differences in IH<80%, median transcutaneous carbon dioxide or median cerebral or renal oxygenation.</p><p><strong>Conclusion: </strong>In preterm infants meeting respiratory stability criteria for CPAP cessation, extended CPAP decreased IH, bradycardia and other hypoxaemia measures compared with weaning to low-flow NC during the 24-hour intervention.</p><p><strong>Trial registration number: </strong>NCT04792099.</p>","PeriodicalId":8177,"journal":{"name":"Archives of Disease in Childhood - Fetal and Neonatal Edition","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11327380/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139745894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Trends in infant mortality due to haemolytic disease and other perinatal jaundice in the USA, 1999-2020.","authors":"Ramesh Vidavalur, Vinod K Bhutani","doi":"10.1136/archdischild-2023-326006","DOIUrl":"10.1136/archdischild-2023-326006","url":null,"abstract":"","PeriodicalId":8177,"journal":{"name":"Archives of Disease in Childhood - Fetal and Neonatal Edition","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41119857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Behrouz Nezafat Maldonado, Julia Lanoue, Benjamin Allin, Dougal Hargreaves, Marian Knight, Chris Gale, Cheryl Battersby
{"title":"Place of birth and postnatal transfers in infants with congenital diaphragmatic hernia in England and Wales: a descriptive observational cohort study.","authors":"Behrouz Nezafat Maldonado, Julia Lanoue, Benjamin Allin, Dougal Hargreaves, Marian Knight, Chris Gale, Cheryl Battersby","doi":"10.1136/archdischild-2023-326152","DOIUrl":"10.1136/archdischild-2023-326152","url":null,"abstract":"<p><strong>Objective: </strong>To describe clinical pathways for infants with congenital diaphragmatic hernia (CDH) and short-term outcomes.</p><p><strong>Design: </strong>Retrospective observational cohort study using the UK National Neonatal Research Database (NNRD).</p><p><strong>Patients: </strong>Babies with a diagnosis of CDH admitted to a neonatal unit in England and Wales between 2012 and 2020.</p><p><strong>Main outcome measures: </strong>Clinical pathways defined by place of birth (with or without colocated neonatal and surgical facilities), transfers, clinical interventions, length of hospital stay and discharge outcome.</p><p><strong>Results: </strong>There were 1319 babies with a diagnosis of CDH cared for in four clinical pathways: born in maternity units with (1) colocated tertiary neonatal and surgical units ('<i>neonatal surgical units</i>'), 50% (660/1319); (2) designated tertiary neonatal unit and transfer to stand-alone surgical centre ('<i>tertiary designated</i>'), 25% (337/1319); (3) non-designated tertiary neonatal unit ('<i>tertiary non-designated'</i>), 7% (89/1319); or (4) non-tertiary unit ('<i>non-tertiary</i>'), 18% (233/1319)-the latter three needing postnatal transfers. Infant characteristics were similar for infants born in <i>neonatal surgical</i> and <i>tertiary designated</i> units. Excluding 149 infants with minimal data due to early transfer (median (IQR) 2.2 (0.4-4.5) days) to other settings, survival to neonatal discharge was 73% (851/1170), with a median (IQR) stay of 26 (16-44) days.</p><p><strong>Conclusions: </strong>We found that half of the babies with CDH were born in hospitals that did not have on-site surgical services and required postnatal transfer. Similar characteristics between infants born in neonatal surgical units and tertiary designated units suggest that organisation rather than infant factors influence place of birth. Future work linking the NNRD to other datasets will enable comparisons between care pathways.</p>","PeriodicalId":8177,"journal":{"name":"Archives of Disease in Childhood - Fetal and Neonatal Edition","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11347235/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139690992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jakob Hibberd, Justin Leontini, Thomas Scott, J Jane Pillow, Martijn Miedema, Peter C Rimensberger, David Gerald Tingay
{"title":"Neonatal high-frequency oscillatory ventilation: where are we now?","authors":"Jakob Hibberd, Justin Leontini, Thomas Scott, J Jane Pillow, Martijn Miedema, Peter C Rimensberger, David Gerald Tingay","doi":"10.1136/archdischild-2023-325657","DOIUrl":"10.1136/archdischild-2023-325657","url":null,"abstract":"<p><p>High-frequency oscillatory ventilation (HFOV) is an established mode of respiratory support in the neonatal intensive care unit. Large clinical trial data is based on first intention use in preterm infants with acute respiratory distress syndrome. Clinical practice has evolved from this narrow population. HFOV is most often reserved for term and preterm infants with severe, and often complex, respiratory failure not responding to conventional modalities of respiratory support. Thus, optimal, and safe, application of HFOV requires the clinician to adapt mean airway pressure, frequency, inspiratory:expiratory ratio and tidal volume to individual patient needs based on pathophysiology, lung volume state and infant size. This narrative review summarises the status of HFOV in neonatal intensive care units today, the lessons that can be learnt from the past, how to apply HFOV in different neonatal populations and conditions and highlights potential new advances. Specifically, we provide guidance on how to apply an open lung approach to mean airway pressure, selecting the correct frequency and use of volume-targeted HFOV.</p>","PeriodicalId":8177,"journal":{"name":"Archives of Disease in Childhood - Fetal and Neonatal Edition","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41102913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Marie-Laure Charkaluk, Gildas Delavoix Kana, Valérie Benhammou, Isabelle Guellec, Mathilde Letouzey, Andrei Scott Morgan, Alexandra Nuytten, Héloïse Torchin, Sabrina Twilhaar, Gilles Cambonie, Stéphane Marret, Pierre Yves Ancel, Véronique Pierrat
{"title":"Neurodevelopment at age 5.5 years according to Ages & Stages Questionnaire at 2 years' corrected age in children born preterm: the EPIPAGE-2 cohort study.","authors":"Marie-Laure Charkaluk, Gildas Delavoix Kana, Valérie Benhammou, Isabelle Guellec, Mathilde Letouzey, Andrei Scott Morgan, Alexandra Nuytten, Héloïse Torchin, Sabrina Twilhaar, Gilles Cambonie, Stéphane Marret, Pierre Yves Ancel, Véronique Pierrat","doi":"10.1136/archdischild-2023-325928","DOIUrl":"10.1136/archdischild-2023-325928","url":null,"abstract":"<p><strong>Objective: </strong>To report neurodevelopment at age 5.5 years according to developmental delay screening with the Ages & Stages Questionnaire (ASQ) in late infancy in preterm-born children.</p><p><strong>Design: </strong>Population-based cohort study, EPIPAGE-2.</p><p><strong>Setting: </strong>France, 2011-2017.</p><p><strong>Participants: </strong>2504 children born at 24-26, 27-31 and 32-34 weeks, free of cerebral palsy, deafness or blindness at 2 years' corrected age.</p><p><strong>Main outcome measures: </strong>Moderate/severe, mild or no disability at age 5.5 years using gross and fine motor, sensory, cognitive and behavioural evaluations. Results of the ASQ completed between 22 and 26 months' corrected age described as positive screening or not.</p><p><strong>Results: </strong>Among 2504 participants, 38.3% had ASQ positive screening. The probability of having moderate/severe or mild disability was higher for children with ASQ positive versus negative screening: 14.2% vs 7.0%, adjusted OR 2.5 (95% CI 1.8 to 3.4), and 37.6% vs 29.7%, adjusted OR 1.5 (1.2 to 1.9). For children with ASQ positive screening, the probability of having neurodevelopmental disabilities at age 5.5 years was associated with the number of domain scores below threshold, very low gestational age and severe neonatal morbidities. For children with ASQ negative screening, this probability was increased for boys and children born small-for-gestational age. For both groups, maternal level of education was strongly associated with outcomes.</p><p><strong>Conclusion: </strong>In preterm-born children, ASQ screening at 2 years' corrected age was associated with neurodevelopmental disabilities at age 5.5 years. However, other factors should be considered when interpreting the ASQ data to draw further follow-up.</p><p><strong>Trial registration number: </strong>2016-A00333-48.</p>","PeriodicalId":8177,"journal":{"name":"Archives of Disease in Childhood - Fetal and Neonatal Edition","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139641532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mark Brian Tracy, Murray Hinder, Stephanie Morakeas, Krista Lowe, Archana Priyadarshi, Matthew Crott, Matthew Boustred, Mihaela Culcer
{"title":"Randomised study of a new inline respiratory function monitor (Juno) to improve mask seal and delivered ventilation with neonatal manikins.","authors":"Mark Brian Tracy, Murray Hinder, Stephanie Morakeas, Krista Lowe, Archana Priyadarshi, Matthew Crott, Matthew Boustred, Mihaela Culcer","doi":"10.1136/archdischild-2023-326256","DOIUrl":"10.1136/archdischild-2023-326256","url":null,"abstract":"<p><strong>Background: </strong>Respiratory function monitors (RFMs) have been used extensively in manikin and infant studies yet have not become the standard of training. We report the outcomes of a new portable, lightweight RFM, the Juno, designed to show mask leak and deflation tidal volume to assist in positive pressure ventilation (PPV) competency training using manikins.</p><p><strong>Methods: </strong>Two leak-free manikins (preterm and term) were used. Participants provided PPV to manikins using two randomised devices, self-inflating bag (SIB) and T-piece resuscitator (TPR), with Juno display initially blinded then unblinded in four 90 s paired sequences, aiming for adequate chest wall rise and target minimal mask leak with appropriate target delivered volume when using the monitor.</p><p><strong>Results: </strong>49 experienced neonatal staff delivered 15 569 inflations to the term manikin and 14 580 inflations to the preterm. Comparing blinded to unblinded RFM display, there were significant reductions in all groups in the number of inflations out of target range volumes (preterm: SIB 22.6-6.6%, TPR 7.1-4.2% and term: SIB 54.8-37.8%, TPR 67.2-63.8%). The percentage of mask leak inflations >60% was reduced in preterm: SIB 20.7-7.2%, TPR 23.4-7.4% and in term: SIB 8.7-3.6%, TPR 23.5-6.2%).</p><p><strong>Conclusions: </strong>Using the Juno monitor during simulated resuscitation significantly improved mask leak and delivered ventilation among otherwise experienced staff using preterm and term manikins. The Juno is a novel RFM that may assist in teaching and self-assessment of resuscitation PPV technique.</p>","PeriodicalId":8177,"journal":{"name":"Archives of Disease in Childhood - Fetal and Neonatal Edition","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11347194/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139711373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lauren Binet, Thierry Debillon, Jonathan Beck, Antoine Vilotitch, Isabelle Guellec, Anne Ego, Marie Chevallier
{"title":"Effect of gestational age on cerebral lesions in neonatal encephalopathy.","authors":"Lauren Binet, Thierry Debillon, Jonathan Beck, Antoine Vilotitch, Isabelle Guellec, Anne Ego, Marie Chevallier","doi":"10.1136/archdischild-2023-326131","DOIUrl":"10.1136/archdischild-2023-326131","url":null,"abstract":"<p><strong>Objective: </strong>To determine the risk on brain lesions according to gestational age (GA) in neonates with neonatal encephalopathy.</p><p><strong>Design: </strong>Secondary analysis of the prospective national French population-based cohort, Long-Term Outcome of NeonataL EncePhALopathy.</p><p><strong>Setting: </strong>French neonatal intensive care units.</p><p><strong>Patients: </strong>Neonates with moderate or severe neonatal encephalopathy (NE) born at ≥34 weeks' GA (wGA) between September 2015 and March 2017.</p><p><strong>Main outcome measures: </strong>The results of MRI performed within the first 12 days were classified in seven injured brain regions: basal ganglia and thalami, white matter (WM), cortex, posterior limb internal capsule, corpus callosum, brainstem and cerebellum. A given infant could have several brain structures affected. Risk of brain lesion according to GA was estimated by crude and adjusted ORs (aOR).</p><p><strong>Results: </strong>MRI was available for 626 (78.8%) of the 794 included infants with NE. WM lesions predominated in preterm compared with term infants. Compared with 39-40 wGA neonates, those born at 34-35 wGA and 37-38 wGA had greater risk of WM lesions after adjusting for perinatal factors (aOR 4.0, 95% CI (1.5 to 10.7) and ORa 2.0, 95% CI (1.1 to 3.5), respectively).</p><p><strong>Conclusion: </strong>WM is the main brain structure affected in late-preterm and early-term infants with NE, with fewer WM lesions as GA increases. This finding could help clinicians to estimate prognosis and improve the understanding of the pathophysiology of NE.</p><p><strong>Trial registration number: </strong>NCT02676063, ClinicalTrials.gov.</p>","PeriodicalId":8177,"journal":{"name":"Archives of Disease in Childhood - Fetal and Neonatal Edition","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139989170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Veerle Heesters, Henriëtte A van Zanten, Maria C den Boer, Arjan B Te Pas, Ruben Sgm Witlox
{"title":"Using the providers' perspective on video review of neonatal procedures to create a roadmap: a qualitative study.","authors":"Veerle Heesters, Henriëtte A van Zanten, Maria C den Boer, Arjan B Te Pas, Ruben Sgm Witlox","doi":"10.1136/archdischild-2023-326528","DOIUrl":"10.1136/archdischild-2023-326528","url":null,"abstract":"<p><strong>Objective: </strong>To examine the providers' perceptions and experiences on implementation of video review (VR) of procedures in the neonatal intensive care unit (NICU).</p><p><strong>Design: </strong>Qualitative study using semi-structured interviews with neonatal care providers about their experiences with VR. Interviews were audio-recorded, transcribed and thematically analysed using the data analysis software Atlas.ti V.22.2.</p><p><strong>Setting: </strong>Providers working in the NICU of the Leiden University Medical Center were interviewed during implementation of VR.</p><p><strong>Results: </strong>In total, 28 NICU staff members were interviewed. The interviewed providers appreciated VR and valued the focus on a safe learning environment. Five overarching themes were identified: (1) added value: providers reported that VR is a powerful tool for reflection on daily practice and serves as a magnifying glass on practice, provides a helicopter view and VR with nursing and medical staff together led to new insights and was seen as highly valuable; (2) preconditions and considerations: the existing culture of trust on the NICU positively influenced providers' perception; (3) adjustment: it was recommended to first let providers attend a VR session, before being recorded; (4) experiences with VR: suggestions were made by the providers regarding the preparation and organisation of VR and the role of the chair; (5) embedding VR: providers considered how to embed VR on the long-term while maintaining a safe learning environment and provided suggestions for expanding.</p><p><strong>Conclusion: </strong>Neonatal care providers appreciated the use of VR and provided viewpoints on how to implement VR successfully, which were used to develop a roadmap with recommendations.</p>","PeriodicalId":8177,"journal":{"name":"Archives of Disease in Childhood - Fetal and Neonatal Edition","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139701620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nadia Ford, Frank Harry Bloomfield, Yannan Jiang, Barbara Elizabeth Cormack
{"title":"Early hypophosphataemia and refeeding syndrome in extremely low birthweight babies and outcomes to 2 years of age: secondary cohort analysis from the ProVIDe trial.","authors":"Nadia Ford, Frank Harry Bloomfield, Yannan Jiang, Barbara Elizabeth Cormack","doi":"10.1136/archdischild-2024-327029","DOIUrl":"https://doi.org/10.1136/archdischild-2024-327029","url":null,"abstract":"<p><strong>Objective: </strong>To investigate in extremely low birthweight (ELBW; <1000 g) babies the associations between refeeding syndrome (serum phosphate <1.4 mmol·L<sup>-1</sup> and serum total calcium>2.8 mmol·L<sup>-1</sup>) and hypophosphataemia in the first week and death or neurodisability at 2 years' corrected age (CA).</p><p><strong>Design: </strong>Secondary cohort analysis of the ProVIDe trial participants with serum biochemistry within 7 days of birth. At 2 years' CA, neurodisability was assessed by Bayley Scales of Infant Development Edition III and neurological examination. Associations between neurodisability and other variables were analysed using t-tests and logistic regression adjusted for sex and smallness-for-gestational age.</p><p><strong>Setting: </strong>Six tertiary neonatal intensive care units (NICUs) in New Zealand.</p><p><strong>Participants: </strong>352 ELBW babies born between 29 April 2014 and 30 October 2018.</p><p><strong>Main outcome measure: </strong>Death or neurodisability at 2 years' CA.</p><p><strong>Results: </strong>Fifty-nine babies died, two after discharge from the NICU. Of the 336 babies who survived to 2 years' CA, 277 had neurodevelopmental assessment and 107 (39%) had a neurodisability. Death or neurodisability was more likely in babies who had refeeding syndrome (aOR 1.96 (95% CI 1.09 to 3.53), p=0.02) and in babies who had hypophosphataemia (aOR 1.74 (95% CI 1.09 to 2.79), p=0.02). Hypophosphataemia was associated with increased risk of death (aOR 2.07 (95% CI 1.09 to 3.95), p=0.03)) and severe hypophosphataemia (<0.9 mmol·L<sup>-1</sup>) with increased risk of death (aOR 2.67 (95% CI 1.41 to 5.00), p=0.002) and neurodisability (aOR 2.31 (95% CI 1.22 to 4.35), p=0.01).</p><p><strong>Conclusions: </strong>In ELBW babies, refeeding syndrome and hypophosphataemia in the first week are associated with death or neurodisability. Until optimal phosphate requirements are determined through further research, monitoring for hypophosphataemia and mitigation strategies are indicated.</p><p><strong>Trial registration number: </strong>ACTRN12612001084875.</p>","PeriodicalId":8177,"journal":{"name":"Archives of Disease in Childhood - Fetal and Neonatal Edition","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141911523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}